These parameters remained borderline significant in multivariable analyses adjusting for age, gender, white blood cell count, cytogenetic risk, type of AML and TP53 VAF, indicating a potential prognostic value of this score (Table 3). This evidence concerns the gene TP53 and acute myeloid leukemia.